ABT-737 synergizes with Bortezomib to kill melanoma cells.
about
Alternative Treatments For Melanoma: Targeting BCL-2 Family Members to De-Bulk and Kill Cancer Stem CellsMicroRNA-26a is strongly downregulated in melanoma and induces cell death through repression of silencer of death domains (SODD)The ratio of Mcl-1 and Noxa determines ABT737 resistance in squamous cell carcinoma of the skinTherapeutic interventions to disrupt the protein synthetic machinery in melanomaErdr1 Suppresses Murine Melanoma Growth via Regulation of Apoptosis.Combining a GSI and BCL-2 inhibitor to overcome melanoma's resistance to current treatments.Applications of nanotechnology for melanoma treatment, diagnosis, and theranostics.miR in melanoma development: miRNAs and acquired hallmarks of cancer in melanoma.Towards combinatorial targeted therapy in melanoma: from pre-clinical evidence to clinical application (review).Combining a BCL2 inhibitor with the retinoid derivative fenretinide targets melanoma cells including melanoma initiating cellsUse of a MCL-1 inhibitor alone to de-bulk melanoma and in combination to kill melanoma initiating cells.Bcl‑2 associated athanogene 4 promotes proliferation, migration and invasion of gastric cancer cells.Proteasome inhibitors against amelanotic melanoma.Targeting the intrinsic apoptosis pathway as a strategy for melanoma therapy.
P2860
Q28084243-F5799C0C-29C4-4692-BFC9-FD53DC5EBB8CQ28280193-BD93BE92-C8B7-41C5-9273-D594C66B9C59Q35966223-57AC5090-7EB7-4F6D-8DB6-A27D5B41C062Q36473355-BE41EFBA-E341-46FF-8DC6-0C04ECD5AACFQ36512628-09D0E382-E379-44C0-89AE-0DA84F481871Q37708989-A153629A-F778-4BBA-9D65-A0231BB21934Q38127412-98F1F363-DE52-498C-AEB1-1B64DF9DD964Q38138933-8CCA52A5-EB33-41EC-BEAE-B6B278FDEB57Q38219616-2DF2AA44-E3DD-4322-8307-9891C275A05CQ38944587-46F895B5-9204-4426-9917-18EDF74C4CDDQ41470758-475ACEF2-BE4E-437D-A9E9-CADCF6B79A8EQ42679623-B2451124-28F1-4D70-BC74-75EC9B8EF5CBQ47141204-6DB898E1-5D33-4530-9AE4-65DEAA2E0CC0Q51746852-DF09BB62-B9F5-40DD-8CF9-832C15E8E52E
P2860
ABT-737 synergizes with Bortezomib to kill melanoma cells.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
ABT-737 synergizes with Bortezomib to kill melanoma cells.
@ast
ABT-737 synergizes with Bortezomib to kill melanoma cells.
@en
type
label
ABT-737 synergizes with Bortezomib to kill melanoma cells.
@ast
ABT-737 synergizes with Bortezomib to kill melanoma cells.
@en
prefLabel
ABT-737 synergizes with Bortezomib to kill melanoma cells.
@ast
ABT-737 synergizes with Bortezomib to kill melanoma cells.
@en
P2093
P2860
P356
P1433
P1476
ABT-737 synergizes with Bortezomib to kill melanoma cells.
@en
P2093
David A Norris
Karl Lewis
Katie A Partyka
Mayumi Fujita
Nathaniel B Goldstein
Rene Gonzalez
Shilo Smith
Steven N Reuland
Yiqun G Shellman
Yuchun Luo
P2860
P304
P356
10.1242/BIO.2011035
P577
2011-11-16T00:00:00Z